NCT04990830View on ClinicalTrials.gov

Effects of Low Molecular Weight Heparin Therapy With Soft-Mist Inhaler for COVID-19 Induced Hypoxemia

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

February 3, 2021

Primary Completion Date

April 21, 2021

Study Completion Date

May 21, 2021

Conditions
COVID-19 Acute Respiratory Distress SyndromeHypoxemia
Interventions
DRUG

Inhaled Low molecular weight heparin

Application with Soft Mist Inhaler

DRUG

Standard Treatment

Control Group

Trial Locations (1)

34093

Istanbul University Medical Faculty, Istanbul

All Listed Sponsors
lead

Istanbul University

OTHER

NCT04990830 - Effects of Low Molecular Weight Heparin Therapy With Soft-Mist Inhaler for COVID-19 Induced Hypoxemia | Biotech Hunter | Biotech Hunter